Shares Outstanding Shares Outstanding n/a Close	300.08M
Shares Change (YoY) Shares Change (YoY) n/a Close	10.11%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	0.75%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	94.56%
Shares Floating Shares Floating n/a Close	264.16M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	686,255
FTD / Avg. Volume FTD / Avg. Volume n/a Close	6.11%

Short Selling Information

The latest short interest is 39.64M, so 13.21% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	39.64M
Short % of Shares Out Short % of Shares Out n/a Close	13.21%
Short % of Float Short % of Float n/a Close	15.03%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	4.98

Valuation Ratios

The PE ratio is -1.62 and the forward PE ratio is -2.31. Pacific Biosciences of California's PEG ratio is 0.25.

PE Ratio PE Ratio n/a Close	-1.62
Forward PE Forward PE n/a Close	-2.31
PS Ratio PS Ratio n/a Close	3.26
Forward PS Forward PS n/a Close	1.3
PB Ratio PB Ratio n/a Close	0.99
P/FCF Ratio P/FCF Ratio n/a Close	-2.37
PEG Ratio PEG Ratio n/a Close	0.25

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Pacific Biosciences of California.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 7.48, with a Debt / Equity ratio of 1.33.

Current Ratio Current Ratio n/a Close	7.48
Quick Ratio Quick Ratio n/a Close	6.59
Debt / Equity Debt / Equity n/a Close	1.33
Debt / EBITDA Debt / EBITDA n/a Close	-2.77
Debt / FCF Debt / FCF n/a Close	-3.17
Interest Coverage Interest Coverage n/a Close	-26.57

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$267,850.43
Profits Per Employee Profits Per Employee n/a Close	$-538,871.3
Employee Count Employee Count n/a Close	575
Asset Turnover Asset Turnover n/a Close	0.12
Inventory Turnover Inventory Turnover n/a Close	1.99

Taxes

Income Tax Income Tax n/a Close	316K
Effective Tax Rate Effective Tax Rate n/a Close	-0.1%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 2.1, so Pacific Biosciences of California's price volatility has been higher than the market average.

Beta Beta n/a Close	2.1
52-Week Price Change 52-Week Price Change n/a Close	n/a
50-Day Moving Average 50-Day Moving Average n/a Close	1.13
200-Day Moving Average 200-Day Moving Average n/a Close	1.57
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	57.96
Average Volume (20 Days) Average Volume (20 Days) n/a Close	11,227,633

Income Statement

In the last 12 months, Pacific Biosciences of California had revenue of 154.01M and earned -309.85M in profits. Earnings per share was -1.13.

Revenue Revenue n/a Close	154.01M
Gross Profit Gross Profit n/a Close	37.28M
Operating Income Operating Income n/a Close	-356.38M
Net Income Net Income n/a Close	-309.85M
EBITDA EBITDA n/a Close	-242.78M
EBIT EBIT n/a Close	-296.12M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-1.13

Full Income Statement

Balance Sheet

The company has 55.37M in cash and 672.43M in debt, giving a net cash position of -617.06M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	55.37M
Total Debt Total Debt n/a Close	672.43M
Net Cash Net Cash n/a Close	-617.06M
Retained Earnings Retained Earnings n/a Close	-2.15B
Total Assets Total Assets n/a Close	860.79M
Working Capital Working Capital n/a Close	378.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -206.06M and capital expenditures -6.19M, giving a free cash flow of -212.25M.

Operating Cash Flow Operating Cash Flow n/a Close	-206.06M
Capital Expenditures Capital Expenditures n/a Close	-6.19M
Free Cash Flow Free Cash Flow n/a Close	-212.25M
FCF Per Share FCF Per Share n/a Close	-0.77

Full Cash Flow Statement

Margins

Gross margin is 24.21%, with operating and profit margins of -231.4% and -201.18%.

Gross Margin Gross Margin n/a Close	24.21%
Operating Margin Operating Margin n/a Close	-231.4%
Pretax Margin Pretax Margin n/a Close	-200.98%
Profit Margin Profit Margin n/a Close	-201.18%
EBITDA Margin EBITDA Margin n/a Close	-157.64%
EBIT Margin EBIT Margin n/a Close	-231.4%
FCF Margin FCF Margin n/a Close	-137.81%

Dividends & Yields

PACB does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for PACB is $1.8, which is 40.6% higher than the current price. The consensus rating is "Hold".

Price Target Price Target n/a Close	$1.8
Price Target Difference Price Target Difference n/a Close	40.6%
Analyst Consensus Analyst Consensus n/a Close	Hold
Analyst Count Analyst Count n/a Close	9

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Scores

Altman Z-Score Altman Z-Score n/a Close	-5.63
Piotroski F-Score Piotroski F-Score n/a Close	3